Navigation Links
AccuVein AV300, First Portable Vein Illumination Device, Now Available on GSA Schedule
Date:6/29/2009

5-Year Contract Makes AccuVein's Device Now Available to Veteran and Military Hospitals

COLD SPRING HARBOR, N.Y., June 29 /PRNewswire/ -- AccuVein LLC today announced a five-year agreement with the U.S. General Services Administration (GSA). This agreement brings the AccuVein AV300, the world's first hand-held, non-contact vein illumination device, to GSA organizations including military and veteran hospitals.

The AccuVein AV300 helps healthcare professionals locate hard-to-find veins. IV starts, blood draws and blood donation (venipuncture) can be a source of patient anxiety and discomfort, and accessing veins in difficult patients can take up to 10 minutes and require multiple needle sticks. Venipuncture is the most common invasive medical procedure with an estimated 2.7 million procedures conducted every day in the United States alone. The AV300 can help reduce the need for multiple needle sticks, with the goal of improving patient care and the time to access veins.

"Adding the AccuVein AV300 on the GSA schedule brings a valuable device to these healthcare professionals at the front-line of patient care, enabling them to see a vein map on the skin to improve the time, comfort and cost of care," said Stephen P. Conlon, President, AccuVein. "We've had strong interest from a broad range of Military, Federal and State medical institutions and the GSA agreement enables greater access to this important advancement in patient care."

Weighing only 10 ounces, the AV300 uses point-and-click technology -- the healthcare professional simply presses a button and positions the device above the patient's skin to display a map on the skin of underlying veins. With a range of hands-free options, the AV300 can quickly switch between a hand-held and hands-free mode, freeing the practitioner's hands to perform the venipuncture.

Government organizations that can purchase the AccuVein AV300 from the GSA Schedule include:

  • The Department of Health and Human Services
  • Indian Health Service and the Office of Tribal Programs
  • Department of Justice
  • Federal Bureau of Prisons
  • Department of Defense
  • VA Medical Centers, Clinics and Military Hospitals

For more information and to see videos of the AccuVein AV300 in action, please visit www.AccuVein.com. AccuVein representatives will also be on-site at the American Association for Clinical Chemistry Annual Meeting and Clinical Lab Expo, Booth 1572, July 19-23, in Chicago, Illinois.

About AccuVein

AccuVein applies advanced technologies to important healthcare challenges. Their innovative AV300 allows practitioners to see a map on the patient's skin of the position of veins, helping caregivers locate veins while they perform the most common invasive medical procedure -- venipuncture. Built using AccuVein's expertise in medical device modernization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. With more than a dozen patents filed worldwide, AccuVein demonstrates an ongoing commitment to invest in improving patient care and patient satisfaction.

For more information on the AccuVein AV300, please visit www.accuvein.com.

About GSA

GSA provides a centralized delivery system of products and services to the federal government, leveraging its enormous buying power to get the best value for taxpayers.

  • Founded in 1949, GSA manages more than one-fourth of the government's total procurement dollars and influences the management of $500 billion in federal assets, including 8,600 government-owned or leased buildings and 213,000 vehicles.
  • GSA helps preserve our past and define our future, as a steward of more than 480 historic properties, and as manager of USA.gov, the official portal to federal government information and services.
  • GSA's mission to provide superior workplaces, expert technology solutions, acquisition services, purchasing and E-Gov travel solutions and management policies, at best value, allows federal agencies to focus on their core missions.

More information is available at http://www.gsa.gov.


'/>"/>
SOURCE AccuVein LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: AccuVein Launches First Portable, Non-Contact Vein Illumination Device
2. Prometheus Launches MyCeliacID(TM), the First Do it Yourself, Saliva-Based Genetic Test Dedicated to Celiac Disease
3. Video: New Online Film Introduces Longevinex Advantage(TM) -- The First Resveratrol-Based Dietary Supplement to Address Both Cellular and Connective Tissue Aging
4. MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care
5. Aegis Living Was Created To Place People First in Senior and Assisted Living Communities
6. Team Type 1 Takes First Place Finish in Race Across America
7. Nations first childrens hospital-based safety store focuses on child injury prevention
8. First Day of Summer Has Come: Enjoy the Summer Sunshine Without Putting Yourself at Risk
9. MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans
10. First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women
11. Cytox Raises Pre-Series A Financing From Management and Existing UK Investors, Welcomes First US Investors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... 2017 , ... Osteitis pubis may be commonplace and seemingly ... occurs when the muscles around the pelvis become inflamed. Over time, untreated osteitis ... as well as accompanying tenderness and weakness. Without proper intervention, it can hinder ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: